Bruker’s User Meeting at HUPO Connect
Learn more about the technology that won the HUPO Science and Technology award in 2020. During this session Bruker customers and cooperation partners will present their exciting results obtained with the timsTOF Pro, PASEF® and 4D-Proteomics™.
Program:
14:00 - 14:15 Gary Kruppa, Ph.D. (Vice President Proteomics, Bruker Daltonics, Czech Republic)
Update on 4D-Proteomics™: dia-PASEF®, prm-PASEF®, PaSER and Run and Done
14:15 - 14:45 Jarrod A. Marto, Ph.D. (Associate Professor of Biological Chemistry and Pharmacology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School)
Next-generation Targeted Acquisition on the timsTOF Pro: PRM-LIVE!
14:45 - 15:00 Nicolai Bache, Ph.D. (Head of Application, Evosep, Denmark)
High-throughput, high sensitivity, nano-flow on Evosep One
15:00 - 15:30 Andreas-David Brunner (Ph.D. student at research group of Prof. Matthias Mann at the Max Planck Institute of Biochemistry - Proteomics and Signal transduction, Germany)
Ultra-high sensitivity MS on a timsTOF enables proteomics analyses of single cells – One by one
15:30 - 15:45 Marshall Bern, Ph.D. (Vice President of Research, Protein Metrics Inc., USA)
Identification of low-abundance proteins in complex mixtures
15:45 - 16:15 Stefan Tenzer, Prof. Dr. (Head of Institute for Immunology, University Medical Center, Mainz, Germany)
Deep coverage single shot phoshoproteomics on the timsTOF Pro
16:15 - 16:30 Break
16:30 - 16:45 Baozhen Shan, Ph.D. (CEO at Bioinformatics Solutions Inc., Canada)
PEAKS solution to 4D-Proteomics™ with timsTOF
16:45 - 17:15 Hans JCT Wessels, Ph.D. (Proteomics scientist, Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboudumc, Netherlands)
Towards routine N-glycopeptide profiling using PASEF® technology and ion mobility aware glycoproteomics software
17:15 - 17:30 Na Pi Parra, Ph.D. (Senior Director of Marketing, Newomics Inc., USA)
Interfacing Newomics MnESI Platform with Bruker MS for Protein and Peptide Analysis
17:30 - 18:00 Robin Park (Director of Bioinformatics, Bruker Daltonics Inc, USA)
Proteomics Data Analysis Platform (IP2) and Real-time Search (PaSER) and beyond
